KUALA LUMPUR: More than RM85mil has been spent to procure 18 types of haemophilia treatment medication between Jan 1 and Oct 30 of this year, says the Health Ministry.
The ministry said that the RM85.7mil spent marked a 65% increase compared to the RM51mil spent last year.
"Of the 18 medication types, 13 were priced through a medical supplies logistics concession, while five were through direct purchases. So far, no patients have had their medication disrupted.
The ministry remains committed to ensuring medication is sufficient for patients," it said in a written Parliamentary reply on Wednesday (Dec 11).
For 2025, the ministry said RM6bil had been allocated for the procurement of pharmaceutical medication stock.
This is about RM460mil (8.3%) more than the RM5.64bil allocation in 2023.
"These allocations will be spent optimally and ensure continuity in medication supplies, including for haemophilia treatments," it said.
The ministry was responding to a question from Rodziah Ismail (Pakatan-Ampang) regarding the status of haemophilia medication in 2024 and the allocations for next year.
